Clinical Trial Update: Improving HIV-1 Control in Africa with Long Acting Antiretrovirals [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on long-acting antiretrovirals for HIV infection in Africa; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: MRC/UVRI and LSHTM Uganda Research Unit | Conditions: HIV-1-infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING